報價延遲最少15分鐘:2025/05/30 07:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.9 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.10/-1.59
|
|
企業價值
427.45M
|
| 資產負債 |
|
每股賬面淨值
2.26
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
87.37M
|
|
每股收益
2.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/30 07:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |